These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29843235)

  • 1. Parkinsonism is a Phenotypical Signature of Amyloidopathy in Patients with Gait Disorders.
    Allali G; Kern I; Laidet M; Armand S; Assal F
    J Alzheimers Dis; 2018; 63(4):1373-1381. PubMed ID: 29843235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonian gait in aging: A feature of Alzheimer's pathology?
    Morel E; Armand S; Assal F; Allali G
    Exp Gerontol; 2020 Mar; 134():110905. PubMed ID: 32135204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes.
    Süssmuth SD; Uttner I; Landwehrmeyer B; Pinkhardt EH; Brettschneider J; Petzold A; Kramer B; Schulz JB; Palm C; Otto M; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2010 Jul; 25(9):1284-8. PubMed ID: 20589870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.
    Liu C; Cholerton B; Shi M; Ginghina C; Cain KC; Auinger P; ; Zhang J
    Parkinsonism Relat Disord; 2015 Mar; 21(3):271-6. PubMed ID: 25596881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.
    Alves G; Brønnick K; Aarsland D; Blennow K; Zetterberg H; Ballard C; Kurz MW; Andreasson U; Tysnes OB; Larsen JP; Mulugeta E
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1080-6. PubMed ID: 20547614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia.
    Koedam EL; van der Vlies AE; van der Flier WM; Verwey NA; Koene T; Scheltens P; Blankenstein MA; Pijnenburg YA
    Alzheimers Dement; 2013 May; 9(3):269-75. PubMed ID: 22846628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal study.
    Brockmann K; Schulte C; Deuschle C; Hauser AK; Heger T; Gasser T; Maetzler W; Berg D
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1427-34. PubMed ID: 26475624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.
    Bäckström DC; Eriksson Domellöf M; Linder J; Olsson B; Öhrfelt A; Trupp M; Zetterberg H; Blennow K; Forsgren L
    JAMA Neurol; 2015 Oct; 72(10):1175-82. PubMed ID: 26258692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.
    Lerche S; Schulte C; Srulijes K; Pilotto A; Rattay TW; Hauser AK; Stransky E; Deuschle C; Csoti I; Lachmann I; Zetterberg H; Liepelt-Scarfone I; Gasser T; Maetzler W; Berg D; Brockmann K
    Mov Disord; 2017 Dec; 32(12):1780-1783. PubMed ID: 29094781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
    Moghekar A; Goh J; Li M; Albert M; O'Brien RJ
    Arch Neurol; 2012 Feb; 69(2):246-50. PubMed ID: 22332192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.
    Buongiorno M; Antonelli F; Compta Y; Fernandez Y; Pavia J; Lomeña F; Ríos J; Ramírez I; García JR; Soler M; Cámara A; Fernández M; Basora M; Salazar F; Sanchez-Etayo G; Valldeoriola F; Barrio JR; Marti MJ
    J Alzheimers Dis; 2017; 55(3):1261-1272. PubMed ID: 27814297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF biomarkers and clinical progression of Parkinson disease.
    Hall S; Surova Y; Öhrfelt A; Zetterberg H; Lindqvist D; Hansson O
    Neurology; 2015 Jan; 84(1):57-63. PubMed ID: 25411441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters.
    Zuo LJ; Piao YS; Li LX; Yu SY; Guo P; Hu Y; Lian TH; Wang RD; Yu QJ; Jin Z; Wang YJ; Wang XM; Chan P; Chen SD; Wang YJ; Zhang W
    Sci Rep; 2017 Mar; 7():44872. PubMed ID: 28332604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
    Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
    Geijselaers SLC; Aalten P; Ramakers IHGB; De Deyn PP; Heijboer AC; Koek HL; OldeRikkert MGM; Papma JM; Reesink FE; Smits LL; Stehouwer CDA; Teunissen CE; Verhey FRJ; van der Flier WM; Biessels GJ;
    J Alzheimers Dis; 2018; 61(1):309-320. PubMed ID: 29154275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Sierra-Rio A; Balasa M; Olives J; Antonell A; Iranzo A; Castellví M; Bosch B; Grau-Rivera O; Fernandez-Villullas G; Rami L; Lladó A; Sánchez-Valle R; Molinuevo JL
    Neurodegener Dis; 2016; 16(1-2):69-76. PubMed ID: 26560503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.